5,384 results match your criteria: "Factor XIII"

Background: Neutrophil Extracellular Traps can contribute to thrombosis via stabilization fibrin network, which is normally conducted by plasma transglutaminase, Factor XIII-A as part of coagulation cascade. The possible presence and activity of FXIII-A in neutrophils or during NETosis is unknown. Here, we investigated potential presence of FXIII-A in neutrophils and participation in NET-fibrinogen interaction.

View Article and Find Full Text PDF

Influence of rainfall on physicochemical characteristics of runoff water and sediments in riverbeds affected by mining and agricultural activities.

Sci Total Environ

December 2024

Sustainable Use, Management and Reclamation of Soil and Water Research Group, Universidad Politécnica de Cartagena, Paseo Alfonso XIII 48, 30203 Cartagena, Spain.

Cartagena-La Union mining district (SE Spain) has unconnected dry riverbeds, which transport mining waste downstream under torrential rain events, polluting a coastal lagoon (Mar Menor). Additionally, in the cropland Campo de Cartagena, agricultural activities promote nitrate and phosphate accumulation in that lagoon. Therefore, this study aimed to evaluate the spatial-temporal trends of sediments and runoff water properties in El Albujón y La Carrasquilla riverbeds.

View Article and Find Full Text PDF

Acquired Factor XIII (FXIII) deficiency is a rare condition often associated with underlying medical conditions or medications. We present a case of a 23-year-old male, who presented with prolonged bleeding from a traumatic ulcer site on his left leg. Initial laboratory investigations revealed a severe deficiency in FXIII activity (30%) and antigen levels (25%), with no evidence of congenital disorders or other underlying pathologies.

View Article and Find Full Text PDF
Article Synopsis
  • - FXIII-A deficiency is a rare bleeding disorder linked to serious complications like brain hemorrhages and miscarriages, with a higher prevalence of a milder form (heterozygous deficiency) found in up to 3.5% of the population.
  • - Individuals with severe FXIII-A deficiency require consistent preventative treatment, while heterozygous individuals, especially women, may only need treatment during specific bleeding events.
  • - Personalized treatment strategies based on individual patient factors (e.g., age, weight, and clinical situation) are essential for optimizing the effectiveness of therapy for FXIII deficiencies.
View Article and Find Full Text PDF

: This study aims to investigate the role of congenital single nucleotide thrombophilia in young females with early recurrent pregnancy loss (RPL). : We studied 120 pregnant females with RPL and 80 matched females as a control with no RPL. Females were aged ≤ 35 years, had at least two consecutive first-trimester RPLs, and the acquired cause of RPL was excluded.

View Article and Find Full Text PDF
Article Synopsis
  • The basic helix-loop-helix (bHLH) superfamily is a significant group of transcription factors in plants, involved in diverse processes like iron homeostasis, but they need further study in peanuts.
  • A genome-wide analysis in peanuts revealed 373 bHLH genes categorized into 14 subfamilies, with findings indicating that most experienced duplication and share similar structures, reflecting their evolutionary background.
  • Specific genes identified showed increased expression in peanut plants under iron deficiency, especially in the 'Silihong' cultivar, suggesting these genes contribute to better tolerance to iron deficiency in that variety.
View Article and Find Full Text PDF

A 63-year-old man, previously diagnosed with multiple autoimmune diseases, developed life-threatening bleeding after gastrectomy for stomach cancer. He survived due to treatment with factor XIII (FXIII) concentrates immediately after his FXIII antigen (Ag) level was reported to be < 5% of normal. Detailed examination by the Japanese Collaborative Research Group on autoimmune coagulation factor deficiencies revealed the presence of anti-FXIII-A and anti-FXIII-B subunit autoantibodies on immunoblot analyses, and thus autoimmune FXIII deficiency (AiF13D) was diagnosed based on the Japanese and international diagnostic criteria.

View Article and Find Full Text PDF

The de novo design and synthesis of yeast chromosome XIII facilitates investigations on aging.

Nat Commun

November 2024

The First Affiliated Hospital of Shenzhen University; Shenzhen Second People's Hospital; Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Institute for Advanced Study, Synthetic Biology Research Center, International Cancer Center of Shenzhen University, Shenzhen, 518039, China.

Article Synopsis
View Article and Find Full Text PDF

Background: Cardiac arrest remains a serious global health issue worldwide which claims for review and improvement. High motivation among resuscitators could lead to high-quality resuscitation and better outcomes. This study aimed to translate and cross-culturally adapt the Cardiopulmonary Resuscitation Motivation Scale into Spanish and assess the psychometric properties of the Spanish version (s-CPRMS).

View Article and Find Full Text PDF

Expression Levels of PF4, ALOX12, ITGA2B, F131A in Pregnant COVID-19 Survivors.

Biochem Genet

November 2024

Medical Molecular Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.

COVID-19 is viral illness caused by SARS-CoV-2. The immediate complications of COVID-19 are well defined and associated with increased mortality. A global effort is required to determine its effects on implantation, fetal growth and labor.

View Article and Find Full Text PDF

Localization of Hemostasis Elements in Aspirated Coronary Thrombi at Different Stages of Evolution.

Int J Mol Sci

November 2024

Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

Article Synopsis
  • The study investigates the structure and evolution of coronary thrombi in STEMI, focusing on the role of activated protein C (APC/PC) and factors like factor XIII (FXIII) and α2 plasmin inhibitor (α2-PI).
  • Histopathological analysis of thrombi from 24 male patients revealed that thrombus age (fresh, lytic, organized) affects the levels and distribution of APC/PC, FXIII, and α2-PI.
  • Key findings indicate that FXIII is highly co-localized with fibrin, while α2-PI increases during thrombus lysis, and NET markers are most prominent in the lytic phase, highlighting potential therapeutic strategies for STEMI.
View Article and Find Full Text PDF

Unlabelled: Dengue virus NS1 protein is a major pathogenic protein. In this study, we examined the role of NS1 in coagulopathy associated with Dengue infection, a common feature of Dengue virus pathogenesis. Since most coagulation factors are produced by hepatocytes and liver is key organ affected during infection, we conducted transcriptomics using total-RNA extracted from Huh7 cells overexpressing NS1 protein.

View Article and Find Full Text PDF

Background: The role of factor XIII in acute bleeding situations is gaining more and more importance. It has previously been shown that prepartum factor XIII activity has a significant impact on postpartum blood loss. Whether factor XIII antigen behaves in a similar manner is unknown.

View Article and Find Full Text PDF

Assessment of Genetic Variants Linked to Susceptibility to Mechanical Prosthetic Valve Thrombosis.

Am J Cardiol

January 2025

Department of Cardiology, Koşuyolu Kartal Heart Training and Research Hospital, Istanbul, Türkiye; Division of Health Sciences, Ardahan University, Ardahan, Türkiye.

Prosthetic valve thrombosis (PVT) is a critical and life-threatening condition driven by multifactorial etiologies, including genetic predispositions. The study was designed as a single-center retrospective manner. Echocardiographic features and genetic test including factor II/prothrombin (G20210A), factor V Leiden (G1691A), factor V R2 (A4070G), apolipoprotein (Apo) B-100 (G10708A), ApoE (C112R), ApoE (R158C), methylenetetrahydrofolate reductase (MTHFR) C677T, MTHFR A1298C, factor XIII G103T (V34L), β-fibrinogen (455G>A), PAI-1 4G/5G, and HPA-1 GPIIIa (T196C) genotyping variations were assessed.

View Article and Find Full Text PDF

The structure of human coagulation factor XIII (FXIII), a heterotetrameric plasma pro-transglutaminase that covalently crosslinks pre-formed fibrin polymers, remains elusive until today. The heterotetrameric complex is composed of two catalytic FXIII-A and two protective FXIII-B subunits. Structural etiology underlying FXIII deficiency has so far been derived from crystallographic structures, all of which are currently available for the FXIII-A2 homodimer only.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the activation and stability of factor XIII subunit FXIII-A, focusing on its unique activation peptide (AP) and how specific mutations affect its function.
  • Recombinant FXIII-A AP variants were created to analyze their role in thrombin activation and transglutaminase activity, using techniques like SDS-PAGE and mass spectrometry for assessment.
  • Key findings highlight that certain mutations to the activation peptide impair FXIII-A stability and activation, indicating that specific amino acid interactions are essential for its functionality in the coagulation process.
View Article and Find Full Text PDF
Article Synopsis
  • Factor XIII (FXIII) is a key coagulation factor involved in blood clotting and is especially important for managing blood in various patient scenarios, like surgeries and trauma.
  • Research shows FXIII affects many other substances crucial for hemostasis, aiding in wound healing and tissue repair.
  • FXIII deficiency is a rare condition that results in prolonged bleeding, complications during surgery, and slower healing, which the article aims to explore further.
View Article and Find Full Text PDF

The third-generation anticoagulants: factors XI, XII, and XIII inhibitors.

Egypt Heart J

October 2024

Department of Cardiology, King George's Medical University, Shahmina Road, Chowk, Lucknow, Uttar Pradesh, 226003, India.

Article Synopsis
  • * Factor XI inhibitors have shown better efficacy and safety compared to enoxaparin in reducing venous thromboembolic incidents, while factor XII inhibitors could also lower bleeding risks based on preliminary animal research.
  • * Further large-scale human studies are needed to confirm the effectiveness of factor XI, XII, and XIII inhibitors in preventing thromboembolic events, as the early results for factors XII and XIII still require validation.
View Article and Find Full Text PDF
Article Synopsis
  • Factor XIII (FXIII) deficiency is a rare but serious blood clotting disorder that can lead to severe bleeding problems.
  • A case study of a 53-year-old man with no major health issues showed he suffered from recurrent bleeding in the brain and a hip hematoma due to FXIII deficiency, confirmed by genetic testing.
  • The case highlights the importance of investigating potential deficiencies in clotting factors in patients who experience unexplained bleeding.
View Article and Find Full Text PDF

Development and Epitope Mapping of Seven Mouse Anti-Human Coagulation Factor XIII-B Subunit Monoclonal Antibodies.

Monoclon Antib Immunodiagn Immunother

October 2024

Department of Molecular Patho-Biochemistry and Patho-Biology, School of Medicine, Yamagata University, Yamagata, Japan.

Article Synopsis
  • Coagulation factor XIII (FXIII) is crucial for clot stability, and a deficiency can lead to severe bleeding risks, prompting researchers to immunize mice to create monoclonal antibodies against its B subunit (FXIII-B).
  • Seven mouse monoclonal antibodies were identified, with one (mAb 5-6C) inhibiting fibrin cross-linking while maintaining FXIII's activity, targeting a specific domain that facilitates FXIII-A's interaction with fibrin.
  • The study also introduced a prototype immunochromatography test for measuring FXIII-B levels and detection of autoantibodies, indicating that these antibodies could have significant clinical applications, including potential thrombosis treatment.
View Article and Find Full Text PDF

Background: Factor XIII plays a key role within the coagulation cascade.

Objective: We aimed to investigate the relevance of factor XIII activity on the outcome of patients with gastrointestinal bleedings.

Methods: In this retrospective, single-center study patients with gastrointestinal bleeding and measurement of factor XIII activity were included.

View Article and Find Full Text PDF

Background/aim: We aimed to determine the genetic risk factors in patients aged 45 years and below with a history of early myocardial infarction (MI), compared to individuals over 60 years of age with no history of MI.

Materials And Methods: In this study, we selected different age groups to more clearly distinguish genetic differences. Accordingly, we compared individuals who had experienced MI at an early age with those who were older and had not experienced any cardiovascular events.

View Article and Find Full Text PDF